Prolonged administration of antithymocyte serum in mice. I. Observations on cellular and humoral immunity.
D000818:Animals; D000831:Animals, Newborn; D000917:Antibody Formation / Q000187:drug effects; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000494:pharmacology*; D001835:Body Weight; D004912:Erythrocytes / Q000276:immunology; D006087:Graft vs Host Reaction / Q000187:drug effects; D006385:Hemagglutination Inhibition Tests; D006433:Hemocyanins; D007109:Immunity / Q000187:drug effects*; D007111:Immunity, Cellular / Q000187:drug effects; D037102:Lectins; D008198:Lymph Nodes / Q000166:cytology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D008223:Lymphoma / Q000209:etiology; D051379:Mice; D010080:Oxazoles; D011120:Polyomavirus; D011817:Rabbits; D051381:Rats; D012710:Serum Albumin, Bovine; D012867:Skin / Q000276:immunology; D016038:Skin Transplantation; D013154:Spleen / Q000166:cytology; D013950:Thymus Gland / Q000276:immunology*; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D037102:Lectins; D010080:Oxazoles; D012710:Serum Albumin, Bovine; D006433:Hemocyanins